Compare Hims and Hers Health Inc (HIMS) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Hims and Hers Health Inc trades at $32.69 (market cap $7.57B), while State Street SPDR S&P Biotech ETF trades at $154.5. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| HIMS | XBI | |
|---|---|---|
Market Cap | $7.57B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $66.18 | $164.28 |
52-Week Low | $14.52 | $85.16 |
Enterprise Value | $7.95B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
